In the last 12 months, insiders at Turn Therapeutics Inc. ($TTRX) filed 19 transactions with the SEC: 9 open-market purchases totaling $308,460 and 0 sales totaling $0. Net insider sentiment: net buying.
Turn Therapeutics Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- GOLDEN ARTHUR F (Director) — 5 transactions totaling $192,873
- Chesed Abraham (Other) — 1 transaction totaling $65,716
- Chaudhary Zuraiz (See Remarks) — 7 transactions totaling $49,872
- Dewhurst Martin William (Director) — 1 transaction totaling $0
- Kester Kent Edward (Director) — 1 transaction totaling $0
View all SEC Filings for Turn Therapeutics Inc. (TTRX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Chaudhary Zuraiz | See Remarks | A | Employee stock option (right to buy) | 80000 | $0.00 | 80,000.0000 | 29,445,183 | 9999.99% | 0.27% |
| April 1, 2026 | Burnam Bradley Evan | Chief Executive Officer | A | Employee stock option (right to buy) | 160000 | $0.00 | 160,000.0000 | 29,445,183 | 9999.99% | 0.54% |
| April 2, 2026 | GOLDEN ARTHUR F | Director | G | Common Stock | 300000 | $0.00 | 360,602.0000 | 29,445,183 | 495.03% | 1.02% |
| April 2, 2026 | Burnam Bradley Evan | Chief Executive Officer | G | Common Stock | 300000 | $0.00 | 15,716,260.0000 | 29,445,183 | 1.87% | 1.02% |
| Jan. 7, 2026 | Dewhurst Martin William | Director | A | Common Stock | 21882 | $0.00 | 21,882.0000 | 29,445,183 | 9999.99% | 0.07% |
| Dec. 12, 2025 | Chaudhary Zuraiz | See Remarks | P | Common Stock | 2500 | $3.50 | 12,500.0000 | 29,445,183 | 25.00% | 0.01% |
| Nov. 24, 2025 | GOLDEN ARTHUR F | Director | P | Common Stock | 9868 | $3.44 | 60,602.0000 | 29,445,183 | 19.45% | 0.03% |
| Nov. 21, 2025 | GOLDEN ARTHUR F | Director | P | Common Stock | 20532 | $2.87 | 50,734.0000 | 29,445,183 | 67.98% | 0.07% |
| Nov. 20, 2025 | Chaudhary Zuraiz | See Remarks | P | Common Stock | 1450 | $2.61 | 9,000.0000 | 29,445,183 | 19.21% | 0.00% |
| Nov. 21, 2025 | Chaudhary Zuraiz | See Remarks | P | Common Stock | 1000 | $3.29 | 10,000.0000 | 29,445,183 | 11.11% | 0.00% |
| Nov. 17, 2025 | Chaudhary Zuraiz | See Remarks | P | Common Stock | 2500 | $3.62 | 7,550.0000 | 29,445,183 | 49.50% | 0.01% |
| Oct. 23, 2025 | Chesed Abraham | Other | P | Common Stock | 14286 | $4.60 | 1,447,268.0000 | 0 | 1.00% | 0.00% |
| Oct. 23, 2025 | GOLDEN ARTHUR F | Director | P | Common Stock | 20202 | $4.95 | 30,202.0000 | 0 | 202.02% | 0.00% |
| Oct. 23, 2025 | Chaudhary Zuraiz | See Remarks | P | Common Stock | 5050 | $4.95 | 5,050.0000 | 0 | 9999.99% | 0.00% |
| Oct. 8, 2025 | Kester Kent Edward | Director | A | Common Stock | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 8, 2025 | Ghodadra Neilesh Shailesh | Chief Medical Officer | A | Common Stock | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 8, 2025 | Gengos Andrew | Director | A | Common Stock | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 8, 2025 | GOLDEN ARTHUR F | Director | A | Common Stock | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 8, 2025 | Chaudhary Zuraiz | See Remarks | A | Employee stock option (right to buy) | 240000 | $0.00 | 240,000.0000 | 0 | 9999.99% | 0.00% |